NCT07265453 A Family-centred Approach Enhancing Cardiovascular Health in Ugandan Adolescents and Their Families
| NCT ID | NCT07265453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MRC/UVRI and LSHTM Uganda Research Unit |
| Condition | Adolescent Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,280 participants |
| Start Date | 2025-07-05 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,280 participants in total. It began in 2025-07-05 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The FaCe-D Study, with funding from the Canadian Institute for Health Research (CIHR) through Global Alliance for Chronic Diseases (GACD) aims to adapt and implement an evidence-based family centred approach (FCA) to prevent cardiovascular diseases (CVD) among adolescents and their families. This 5-year implementation science study will be conducted in 16 villages in Jinja district and another 16 in Kampala beginning April 2024 to evaluate the effectiveness of FCA in reducing the risk of CVD in Uganda and to assess feasibility, adoption, while measuring the costs of implementation. The study will be implemented by a group of researchers from MRC/UVRI \& LSHTM, University of British Columbia (Canada), TASO (Uganda) and University of California San Francisco (UCSF) - USA with guidance from the Ministry of Health - Uganda.
Eligibility Criteria
Inclusion Criteria: * Aged 10 -19 years * Household head/parent has provided consent/permission * Planning to continue staying in the study village for the next 12 months Exclusion Criteria: * In a boarding school or planning to join a boarding school * Pregnant or lactating * Known to have a chronic condition such as mental illness * The adolescent does not assent or consent
Contact & Investigator
Prof Rachel King, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07265453 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 19 Years, studying Adolescent Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07265453 currently recruiting?
Yes, NCT07265453 is actively recruiting participants. Contact the research team at arthur.namara@mrcuganda.org for enrollment information.
Where is the NCT07265453 trial being conducted?
This trial is being conducted at Jinja, Uganda, Kampala, Uganda.
Who is sponsoring the NCT07265453 clinical trial?
NCT07265453 is sponsored by MRC/UVRI and LSHTM Uganda Research Unit. The principal investigator is Prof Rachel King, PhD at University of California, San Francisco. The trial plans to enroll 1,280 participants.